Navigation Links
Netsmart Technologies Selected by Wake County, N.C. to Provide Behavioral Healthcare Software and Implementation Services
Date:7/8/2008

Netsmart is Now Technology Partner of Choice for Nearly 20 North Carolina

Providers and Local Management Entities (LMEs)

GREAT RIVER, N.Y., July 8 /PRNewswire/ -- Netsmart Technologies, Inc., a leading provider of enterprise-wide software and services for health and human services organizations, today announced it has signed a contract with Wake County, North Carolina, to provide behavioral healthcare software and related implementation services. Terms of the agreement were not disclosed.

Wake County Human Services (WCHS) will utilize Netsmart's Avatar Practice Management software for behavioral health services management, client scheduling, billing, accounts receivables and reporting. In addition, the county will use Avatar Clinician Workstation for key behavioral health clinical activities, including assessment, progress notes, treatment planning and reporting.

Netsmart is now the technology partner of choice for more North Carolina providers and Local Management Entities (LMEs) combined than any other software company.

"Our more than 20 years experience serving a variety of North Carolina providers and LMEs will help us meet the wide ranging needs of Wake County," said James L. Conway, chief executive officer, Netsmart Technologies. "We look forward to serving as Wake County's technology partner as they provide high quality care to consumers in an efficient, cost-effective manner."

WCHS provides social services, public health, mental health, job training, child support and housing services through 27 locations and provides support for consumers through 82 agency services. WCHS already utilizes Netsmart's Insight software for public health clinic management.

The Netsmart system will provide an end-to-end resource for WCHS, including managing information for service authorizations, clinical and electronic medical record (EMR) documentation, billing, and payment tracking.

"While in the process of
'/>"/>

SOURCE Netsmart Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Netsmart Technologies Acquires Largest Provider of Software for Private Practice Mental Health Providers and Therapists
2. Netsmart Technologies Introduces the Netsmart Connect(TM) Suite of Solutions for Behavioral and Public Healthcare
3. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
4. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
5. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
6. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
7. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
8. Advanced technologies aim to transform the coaching of top athletes
9. Global Med Technologies(R) Extends Its Worldwide Outreach
10. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
11. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...wswire/ Bayer HealthCare,has donated hundreds of ...y,(CFBNJ) in response to an urgent call from Gove...es to help restock supplies at the state,s food ba...bin/prnh/20081120/NETH138 ) , Mary Lou Panzano...ing,manager, Field Communications, welcomed Samu...
(Date:11/20/2008)...vestor group in Trinity,Biotech plc (Nasdaq: TR...,diagnostic products whose shares are traded in t..., is encouraged that Clint Severson has joined the...g on the news, Tom Reidy stated, "We are delighted... director, bringing the total of independent,dire...
(Date:11/20/2008)...s were infected last year , , THURSDAY, ...ealth officials recommended routine HIV testing fo...-miss, and the AIDS epidemic marches on. , This...sting methods, according to participants at a conf... designed to review the state of the AIDS epidemic...
(Date:11/20/2008)...o lower your risk for type,2 diabetes and heart d...ivity,three times a day. Ten times three -- it,s ...s for Disease Control and Prevention recommend to ...holesterol and lose weight. , In the United...nd heart,disease is the leading cause of death. B...
Breaking Medicine News(10 mins):Health News:Bayer HealthCare Donates Hundreds of Food Items to Community Food Bank of New Jersey in Response to Governor's Plea to Help the State's Population in Need 2Health News:Investor Group Commends Clint Severson for Joining Trinity Biotech's Board of Directors 2Health News:U.S. Lags on HIV Testing Goals 2Health News:U.S. Lags on HIV Testing Goals 3Health News:10 Minutes at a Time: Simple Steps to Get Moving and Reduce Your Risk of Diabetes and Heart Disease 2
...income can make a big difference in helping middle...e was at the upper end," said Meredith Minkler, an...sue of the New England Journal of Medicine. "We al... the very poor and the very rich. To find that the...
...itiative at Roswell Park Cancer Institute (RPCI) i...alth //after they are diagnosed with breast cancer...ion of cancer recurrence. The comprehensive study..., PhD, and Christine Ambrosone, PhD, Department of...
... clinical trial that helped gain U.S. Food and Dru...for Hunter disease has been// published online by ...Dr. Joseph Muenzer, an associate professor in the ...hool of Medicine. Muenzer led the Phase II/III cli...
...e government in Northern Ireland will lead to the ...lementation// of an e-prescriptions service. The...Safety has announced that community pharmacies acr...th an electronic system to transfer prescriptions ...
Other Medicine News:Health News:The higher the income the lower the disability rates! 2Health News:Study Focuses on Women's Health After Breast Cancer 2Health News:Idursulfase Is Effective Treatment for Hunter Syndrome 2Health News:Idursulfase Is Effective Treatment for Hunter Syndrome 3
(Date:11/20/2008)...ewswire/ -- Clinical data from a prospective,regi...Symposium shows DVT,treatment with the Trellis(R)..., Inc. (Santa Clara, CA) successfully breaks up th.... , This technique, called isolated pharmac...e quickly and safely than current catheter-directe...
(Date:11/19/2008)...not achieve statistical significance , , IS...rmos Corporation (Nasdaq: PARS ) today announced...opical NanoEmulsion (NE) drug delivery technology ... , The multi-center, randomized, double-blinde...nd efficacy of the Company,s 3% Diclofenac Diethan...
(Date:11/18/2008)...RNewswire-FirstCall/ -- NeuroDiscovery Ltd (ASX:,...d drug development Company,and Sosei Group Corpo...ng,international biopharmaceutical company, today...er pivotal pre-clinical efficacy data for NSL-043/...herapy for neuropathic pain and has,successfully ...
(Date:11/18/2008)...enroll newly diagnosed, elderly AML patients , ...ator Pharmaceuticals today announced that the firs... clinical study of CPX-351 (Cytarabine:Daunorubici...osed acute myeloid leukemia (AML). , , The ...the Weill Medical College of Cornell University ...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3Cytochroma Appoints R Richard Wieland II As CFO 5293 1Cytochroma Appoints R Richard Wieland II As CFO 5293 2Medifast Announces First Quarter 2008 Financial Results 18997 1Medifast Announces First Quarter 2008 Financial Results 18997 2Medifast Announces First Quarter 2008 Financial Results 18997 3Medifast Announces First Quarter 2008 Financial Results 18997 4Medifast Announces First Quarter 2008 Financial Results 18997 5Medifast Announces First Quarter 2008 Financial Results 18997 6Medifast Announces First Quarter 2008 Financial Results 18997 7Medifast Announces First Quarter 2008 Financial Results 18997 8Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE 28TM 29 Brand Heparin Coated Thoracic Drainage Catheters Used for Autotransfusion During 18992 1Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE 28TM 29 Brand Heparin Coated Thoracic Drainage Catheters Used for Autotransfusion During 18992 2Newsweek International Editions 3A Highlights And Exclusives May 19 2008 5290 1Newsweek International Editions 3A Highlights And Exclusives May 19 2008 5290 2Newsweek International Editions 3A Highlights And Exclusives May 19 2008 5290 3Newsweek International Editions 3A Highlights And Exclusives May 19 2008 5290 4Newsweek International Editions 3A Highlights And Exclusives May 19 2008 5290 5
...w Dissociation from HCV,Protease , ,WASHINGTON, Ma...etwork/ -- InterMune, Inc. (Nasdaq: ITMN) today pr...titis C virus (HCV) NS3/4A,protease inhibitor, ITM...e Disease Week (DDW) meeting being held May 19-24 ...ct #M1816) examined,ITMN-191 potency and binding k...
... FDA for long-term maintenance,treatment of COPD b...ed formoterol fumarate provides improved lung func... patient quality of,life, and positive safety prof... Data presented at the,International Conference of...hat Perforomist (formoterol fumarate) Inhalation,S...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 4InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: